Women’s Health Horizon 2026 SF Summit I Pitch Competition Finalist

National Conference of State Legislatures Health Innovations Task Force Ai/ML speaker July 2026

WHYY Coverage: Philadelphia nurse hopes new tool will more accurately predict women at highest risk for postpartum hemorrhage, July 2026

Venturium 2026 Spring Forum featured presenter

PACT Healthcare-Life Science Startup Winner – Philadelphia PA

BioNJ Investor Forum 2026 | Presenter

Southeast Venture Showcase Presenter I Nashville 2026/2025

BioLabs Investor Day presenter I Philadelphia 2026

Catalytic Impact Foundation I Pitch Competition Finalist 2026

BIO North Texas Life Science Summit - Technology Transfer Showcase

Vasowatch was one of six companies selected to present at BIO North Texas' Technology Transfer Showcase representing Vanderbilt University.

HLTH Women's Health Track Presenter

Vasowatch was selected to present our postpartum hemorrhage biomarker at HLTH's Women's Health track.

2Flo Ventures Women's Health Innovations - Life Science & Biotech Showcase Presenter

Vasowatch was invited to present at 2Flo Ventures Health Equity Investing Symposium: Women's Health Edition, highlighting investments and innovations in women's health on September 18, 2025.

2nd Place | Philadelphia Startup World Cup

Vasowatch earned second place at the Philadelphia Regional Startup World Cup Pitch Competition, receiving $10,000 and a six-month Innovation Nest membership to support its upcoming 300-patient clinical pilot at Pennsylvania Hospital. The recognition highlights Vasowatch’s mission to improve maternal health outcomes with postpartum hemorrhage risk prediction technology.

2nd Place | TIE 2025 Women's Pitch Competition

Excited to announce we took 2nd place in the TIE 2025 Women's Pitch Competition in Philadelphia on August 14, 2025 out of a field of 30 applicants! We look forward to joining the global cohort and building awareness of Vasowatch's potential to impact global maternal health.

CDVCA 2025 Unlock Capital National Cohort

One of thirty businesses selected to participate in the Community Development Venture Capital Alliance (CDVCA) 2025 national cohort. CDVCA is working to build and strengthen businesses in under-invested markets like maternal health. Participation in the cohort resulted in advocacy, education, communications and best practice dissemination to strengthen Vasowatch's commercialization strategy and investment positioning.

Semi-Finalist | MIT Solve's 2025 Global Health Challenge

We are excited to share that our solution, Vasowatch Inc, was selected as a semi-finalist in MIT Solve’s 2025 Global Health Challenge. Learn more about the challenge and our solution here:

https://solve.mit.edu/challenges/2025-global-health-challenge#solutions

HiveBio inaugural cohort 2025

Vasowatch was selected as one of ten companies to participate in this inaugural hybrid accelerator designed to provide support to underrepresented life science entrepreneurs.

MEDCity Invest Pitch Perfect presenter: HealthTech Payer/Provider Track

Vasowatch was featured as one of 24 innovators representing the best of current innovation in healthcare May 21, 2025.

Startup302 Life Science Pitch Competition - 2nd Place

Vasowatch was a finalist in the Delaware Prosperity Partnership's Startup302 Life Science Pitch Competition, focused on highlightiing high-growth, early-stage startups led by underrepresented founders. Vasowatch was one of nine companies selected from 100 entrants that have the potential to support Delaware's statewide economic development efforts to attract, grow and retain businesses, build a stronger entrepreneurial and innovation ecosystem, and support private employers in identifying, recruiting, and developing talent.

Seed2Table Featured Presenter

Vasowatch was one of five life science companies selected by Seed2Table, an organization that hosts exclusive events that connect startups with investors, influencers, government, and communities, to present at their May 7, 2025 Washington DC forum.

UCSF Rosenman Institute Innovators Semi-Finalist

Rosenman Innovators, a Med Tech accelerator program designed to catapult early-stage startups to the forefront of the industry, selected Vasowatch as a semi-finalist in their 2025 cohort.

Frontiers 2025 Startup Pitch Showcase

Featured startup at national event envisioning the future of Biotech at the Frontiers of Healthcare, AI, and Space. This gathering of investors, founders, and industry experts offered the opportunity to discuss trends, success stories, and transformative ideas driving the next wave of innovation.

What would it look like to predict Postpartum Hemorrhage? A Conversation with Christine Rohan & Dr. James Weimer

Vasowatch was honored to have our CEO, Christine Rohan, and Co-Founder, James Weimer, appear on a recent episode of the Making Sense of Pregnancy podcast. Check it out now!

Comcast NBCUniversal LIFT Labs "Top Pitch" Recipient

Vasowatch Inc was awarded the top prize at the January 30, 2025 "Top Pitch" event hosted at Comcast NBCUniversal LIFT Labs. Thanks to judges Kathleen Brunner, Mahesh Chand and Marc Lederman and sponsors the Philadelphia Alliance for Capital and Technologies (PACT), TiE Philadelphia and Ben Franklin Technology Partners of Southeastern Pennsylvania.

Mid-Atlantic Diamond Ventures Winter Forum Presenter

Mid-Atlantic Diamond Ventures (MADV) is an independent organization that assists emerging technology=based companies in their effort to build sustainable businesses by better positioning them for funding while increasing value at an early and crucial stage.